Hospital-Based Contingency Management
Launched by OREGON HEALTH AND SCIENCE UNIVERSITY · Aug 23, 2022
Trial Information
Current as of July 24, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Contingency management (CM), an evidence-based strategy that utilizes a reward-based system as positive reinforcement, has been most robustly studied in the outpatient setting, but also has the potential to improve hospital care for patients with stimulant use disorder. The hospital is a challenging environment for people who use drugs. Conflicts with staff often result from in-hospital substance use, prolonged time off the unit, and missing medications, leading to negative health outcomes and re-admissions. By relying on positive rewards to encourage positive health behaviors, CM has the p...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Be 18 years of age or older
- • Have moderate to severe stimulant use disorder, as diagnosed using DSM-5 criteria for stimulant use disorder by an addiction medicine provider
- • Have an anticipated hospital length of stay greater than 2 weeks
- • Be able to use a smartphone and agree to download and use the Affect app as part of study-related procedures
- • Be English speaking and be able to understand explanations of study procedures and the informed consent to participate
- Exclusion Criteria:
- • Unable to engage in the intervention due to cognitive impairment or altered mental status
- • Unable to engage in the intervention due to acute medical/mental health issues, per judgement of the research assistant
About Oregon Health And Science University
Oregon Health and Science University (OHSU) is a leading academic medical center dedicated to advancing health through research, education, and patient care. As a prominent sponsor of clinical trials, OHSU leverages its extensive expertise in various medical fields to facilitate innovative research aimed at improving patient outcomes. The institution is committed to ethical standards and rigorous scientific methodologies, fostering collaborations that enhance the development of new therapies and interventions. With a focus on translating research discoveries into clinical practice, OHSU plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Portland, Oregon, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials